Company intelligence / Profile preview

Juno OTC

London, United Kingdom

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Juno is a women's health company focused on decoding the vaginal microbiome to improve health outcomes. The company offers a direct-to-consumer vaginal microbiome testing kit that utilizes high-resolution sequencing to provide personalized insights into vaginal health. By leveraging its proprietary Juno Bio Knowledge Engine, the company aims to transition from diagnostics to therapeutics, developing targeted interventions for conditions such as bacterial vaginosis and yeast infections. Juno's mission is to close the gender health gap by providing data-driven solutions for often-overlooked women's health issues.

Therapeutic areas: Women's HealthInfectious Diseases
Modalities: Microbial therapyDiagnostic test
Industry: Molecular Diagnostics

Partnerships

Illumina Accelerator

Beyond the preview

Go deeper on Juno OTC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Juno OTC.

Explore the full profile